Viewing StudyNCT05165264



Ignite Creation Date: 2024-05-06 @ 5:00 PM
Last Modification Date: 2024-10-26 @ 2:20 PM
Study NCT ID: NCT05165264
Status: RECRUITING
Last Update Posted: 2022-02-25
First Post: 2021-12-08

Brief Title: A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric Cancer
Sponsor: Bristol-Myers Squibb
Organization: Bristol-Myers Squibb

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-02-16
Start Date Type: ACTUAL
Primary Completion Date: 2026-12-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2021-12-08
First Submit QC Date: December 8 2021
Study First Post Date: 2021-12-21
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-02-24
Last Update Post Date: 2022-02-25
Last Update Post Date Type: ACTUAL